Latest filing published 07 Apr 2022 for MoonLake Immunotherapeutics.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Helix Holdings LLC: trading record in brief
This profile gathers the share dealings of Helix Holdings LLC in MoonLake Immunotherapeutics. The record holds 2 filings, for trades running from 22 October 2020 to 5 April 2022.
On the market, this insider has only ever bought: 1 purchase, €3.6M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 7 April 2022 came the latest disclosure, a transaction in MoonLake Immunotherapeutics. The last purchase on record was published on 22 October 2020, which is 2,209 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Helix Holdings LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,785,000 shares0Class A Ordinary SharesSEC:0001213900-22-018751:0
- 430,000 shares@ US$10.00100.0% of flowClass A Ordinary SharesSEC:0001213900-20-032859:0Canonical exit: 20 Jan 2021 (T+90)
2 of 1 declaration
